The Ministry of Health supported the inclusion of new nosologies in the drug supply program for patients with cardiovascular diseases (CVD). We are talking about chronic diseases.
The Ministry of Health is considering expanding the program of preferential drug provision for patients who have suffered acute cardiovascular events. The director of the Department of Drug Supply and Regulation of Medical Products spoke about this at the online conference “Cardiovascular diseases: treatment and prevention during a pandemic” on May 18 Elena Astapenkoreports the Pharmaceutical Bulletin.
The project is being developed by the ministry together with key freelance specialists, she added.
Member of the Federation Council Committee on Social Policy Vladimir Krugly clarified that the government has been proposed to expand the “Health Development” program through measures to improve medical care for patients with chronic cardiovascular diseases. It is proposed to provide subsidies to the regions in the budget for 2022–2024 to improve the diagnosis, recording, treatment, rehabilitation and clinical observation of such patients. According to a member of the State Duma Committee on Health Protection Alexandra Petrovacardiologists have experience that can form the basis of the program.
Since 2020, Russia has been implementing a program to prevent complications after acute cerebrovascular accident, myocardial infarction, coronary artery bypass surgery, coronary angioplasty with stenting and catheter ablation for CVD. Patients who have suffered the listed cardiovascular events receive free medications at the clinic for a year. We are talking about citizens who do not have the right to preferential drug coverage. For the program, by order of the Ministry of Health, a list of drugs from 23 INNs was created.
The regions are allocated 10.15 billion rubles annually from the federal budget for the purchase of these drugs. The program will last until the end of 2023.
Under current regulations, patients receive free medications for a year after a cardiovascular event. The Ministry of Health plans to extend the period for issuing drugs by two years.